AcelRx Pharmaceuticals, Inc. (ACRX)

3.40
0.02 0.59
NASDAQ
Prev Close 3.38
Open 3.38
Day Low/High 3.31 / 3.47
52 Wk Low/High 1.65 / 5.05
Volume 1.00M
Exchange NASDAQ
Shares Outstanding 78.76B
Market Cap 266.20M
Div & Yield N.A. (N.A)
AcelRx Pharmaceuticals Shareholder Alert: Former SEC Attorney Willie Briscoe And Powers Taylor Investigate Possible Breaches Of Fiduciary Duty By Officers And Directors

AcelRx Pharmaceuticals Shareholder Alert: Former SEC Attorney Willie Briscoe And Powers Taylor Investigate Possible Breaches Of Fiduciary Duty By Officers And Directors

Former United States Securities and Exchange Commission attorney Willie Briscoe, founder of The Briscoe Law Firm, PLLC, and the securities litigation firm of Powers Taylor LLP announce that a federal class action...

INVESTOR ALERT: Class Action Lawsuit Against AcelRx Pharmaceuticals, Inc. Filed By Glancy Binkow & Goldberg LLP

INVESTOR ALERT: Class Action Lawsuit Against AcelRx Pharmaceuticals, Inc. Filed By Glancy Binkow & Goldberg LLP

Glancy Binkow & Goldberg LLP, representing investors of AcelRx Pharmaceuticals, Inc.

Strong On High Volume: AcelRx Pharmaceuticals (ACRX)

Strong On High Volume: AcelRx Pharmaceuticals (ACRX)

Trade-Ideas LLC identified AcelRx Pharmaceuticals (ACRX) as a strong on high relative volume candidate

Why AcelRx Pharmaceuticals (ACRX) Stock Hit a One-Year Low Today

Why AcelRx Pharmaceuticals (ACRX) Stock Hit a One-Year Low Today

Shares of AcelRx Pharmaceuticals (ACRX) plummeted to a 52-week low of $5.27 on Friday after the company announced a delay in resubmitting Zalviso for FDA approval.

The Best Hedge Fund You've Never Heard Of and Its Top 5 Stock Picks

The Best Hedge Fund You've Never Heard Of and Its Top 5 Stock Picks

It's not the hedge fund mogul you expect.

Perilous Reversal Stock: AcelRx Pharmaceuticals (ACRX)

Perilous Reversal Stock: AcelRx Pharmaceuticals (ACRX)

Trade-Ideas LLC identified AcelRx Pharmaceuticals (ACRX) as a "perilous reversal" (up big yesterday but down big today) candidate

4 Biotech Stocks Under $10 to Trade for Breakouts

4 Biotech Stocks Under $10 to Trade for Breakouts

These under-$10 biotech stocks are within range of triggering breakout trades.

Today's Dead Cat Bounce Stock: AcelRx Pharmaceuticals (ACRX)

Today's Dead Cat Bounce Stock: AcelRx Pharmaceuticals (ACRX)

Trade-Ideas LLC identified AcelRx Pharmaceuticals (ACRX) as a "dead cat bounce" (down big yesterday but up big today) candidate

Why AcelRx Pharmaceuticals (ACRX) Stock Is Plummeting Today

Why AcelRx Pharmaceuticals (ACRX) Stock Is Plummeting Today

AcelRx Pharmaceuticals (ACRX) plummeted Monday after the FDA rejected the company's painkiller dispensing device Zalviso.

FDA Rejects AcelRx Painkiller Dispensing Device (Update)

FDA Rejects AcelRx Painkiller Dispensing Device (Update)

AcelRx believes it can gather all the requested information and re-submit Zalviso to the FDA before the end of the year.

AcelRx Pharmaceuticals (ACRX) Moving On Heavy Volume In The Pre-Market Hours

AcelRx Pharmaceuticals (ACRX) Moving On Heavy Volume In The Pre-Market Hours

Trade-Ideas LLC identified AcelRx Pharmaceuticals (ACRX) as a pre-market mover with heavy volume candidate

4 Biotech Stocks Breaking Out on Big Volume

4 Biotech Stocks Breaking Out on Big Volume

These biotech stocks rising on unusual volume are within range of triggering breakout trades.

Biotech Stock Mailbag: AcelRx, Yellen Aftermath, Nymox

Biotech Stock Mailbag: AcelRx, Yellen Aftermath, Nymox

Biotech columnist Adam Feuerstein answers readers' questions about health care companies.

Biotech Stock Mailbag: MannKind, Bluebird, Northwest Bio, More '14 Tradable Biotech Events

Biotech Stock Mailbag: MannKind, Bluebird, Northwest Bio, More '14 Tradable Biotech Events

Biotech columnist Adam Feuerstein answers readers' questions about health care companies.

5 Stocks Spiking on Unusual Volume

5 Stocks Spiking on Unusual Volume

Often when above-average volume moves into an equity, it precedes a large spike in volatility.

First Week of August 16th Options Trading For AcelRx Pharmaceuticals (ACRX)

First Week of August 16th Options Trading For AcelRx Pharmaceuticals (ACRX)

Investors in AcelRx Pharmaceuticals Inc saw new options become available this week, for the August 16th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the ACRX options chain for the new August 16th contracts and identified one put and one call contract of particular interest.

Oversold Conditions For AcelRx Pharmaceuticals (ACRX)

Oversold Conditions For AcelRx Pharmaceuticals (ACRX)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

AcelRx Pharmaceuticals is Now Oversold (ACRX)

AcelRx Pharmaceuticals is Now Oversold (ACRX)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

First Week of ACRX December 20th Options Trading

First Week of ACRX December 20th Options Trading

Investors in AcelRx Pharmaceuticals Inc saw new options begin trading this week, for the December 20th expiration. One of the key data points that goes into the price an option buyer is willing to pay, is the time value, so with 239 days until expiration the newly trading contracts represent a possible opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration.

Interesting ACRX Put And Call Options For May 17th

Interesting ACRX Put And Call Options For May 17th

Investors in AcelRx Pharmaceuticals Inc saw new options become available this week, for the May 17th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the ACRX options chain for the new May 17th contracts and identified one put and one call contract of particular interest.

First Week of ACRX February 2014 Options Trading

First Week of ACRX February 2014 Options Trading

Investors in AcelRx Pharmaceuticals Inc saw new options become available this week, for the February 2014 expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the ACRX options chain for the new February 2014 contracts and identified one put and one call contract of particular interest.

A Very Shallow Pullback

Conditions still favor the bulls.

First Week Of ACRX January 2014 Options Trading

First Week Of ACRX January 2014 Options Trading

Investors in AcelRx Pharmaceuticals Inc saw new options begin trading this week, for the January 2014 expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the ACRX options chain for the new January 2014 contracts and identified one put and one call contract of particular interest.

5 Stocks With Big Insider Buying

5 Stocks With Big Insider Buying

Insiders at these companies have been scooping up shares of their own stock lately.

Top Insider Trades: AGCO VVUS INWK ACRX

Top Insider Trades: AGCO VVUS INWK ACRX

The top 10 open-market insider purchases and sales filed at the SEC Tuesday.

Oversold Conditions For AcelRx Pharmaceuticals (ACRX)

Oversold Conditions For AcelRx Pharmaceuticals (ACRX)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

Top Insider Trades: ACW ZINC ACRX FCX

Top Insider Trades: ACW ZINC ACRX FCX

The top 10 open-market insider purchases and sales filed at the SEC Monday.

First Week Of ACRX June 2014 Options Trading

First Week Of ACRX June 2014 Options Trading

Investors in AcelRx Pharmaceuticals Inc saw new options begin trading this week, for the June 2014 expiration. One of the key data points that goes into the price an option buyer is willing to pay, is the time value, so with 241 days until expiration the newly trading contracts represent a potential opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration.

AcelRx Pharmaceuticals Becomes Oversold (ACRX)

AcelRx Pharmaceuticals Becomes Oversold (ACRX)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

5 Stocks Poised for Breakouts

5 Stocks Poised for Breakouts

These stocks look ready to break out and trade higher from current levels.

TheStreet Quant Rating: D- (Sell)